Adrian Murphy
Impact in
Papers in
- Oncology 39
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 4
-
- Fibroblast Growth Factor Research 6
- Co-authors
- Lei Zheng (15 shared papers)Arsen Osipov (4 shared papers)Daniel V.T. Catenacci (12 shared papers)Do‐Youn Oh (11 shared papers)Mitesh J. Borad (11 shared papers)Ghassan K. Abou‐Alfa (10 shared papers)Christine Lihou (9 shared papers)Hui‐Ling Zhen (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (5 papers)Cancer Research (4 papers)The Oncologist (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
Adrian Murphy
55 papers receiving 2.7k citations
Adrian Murphy's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.3k
- Surgery 1.1k
- Cancer Research 322
- Immunology 409
- Pulmonary and Respiratory Medicine 569
Countries citing papers authored by Adrian Murphy
This map shows the geographic impact of Adrian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Murphy more than expected).
Fields of papers citing papers by Adrian Murphy
This network shows the impact of papers produced by Adrian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Murphy. The network helps show where Adrian Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Hit paper breakdown → | 2020 | 1021 |
| 2 | 2016 | 368 | |
| 3 | 2016 | 211 | |
| 4 | 2019 | 179 | |
| 5 | 2016 | 96 | |
| 6 | 2019 | 70 | |
| 7 | 2019 | 69 | |
| 8 | 2016 | 59 | |
| 9 | 2019 | 58 | |
| 10 | 2022 | 54 | |
| 11 | 2019 | 54 | |
| 12 | 2016 | 46 | |
| 13 | 2019 | 43 | |
| 14 | 2021 | 38 | |
| 15 | 2020 | 37 | |
| 16 | 2015 | 29 | |
| 17 | 2020 | 27 | |
| 18 | 2024 | 27 | |
| 19 | 2017 | 24 | |
| 20 | 2018 | 21 |
About Adrian Murphy
Adrian Murphy is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 56 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Pancreatic and Hepatic Oncology Research (11 papers), Fibroblast Growth Factor Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Immunotherapy and Immune Responses (4 papers), Peptidase Inhibition and Analysis (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (1.3k citations), Surgery (1.1k citations), Cancer Research (322 citations), Immunology (409 citations) and Pulmonary and Respiratory Medicine (569 citations). Adrian Murphy has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Lei Zheng, Arsen Osipov, Daniel V.T. Catenacci, Do‐Youn Oh, Mitesh J. Borad, Ghassan K. Abou‐Alfa, Christine Lihou, Hui‐Ling Zhen, Antoine Hollebecque and Gina M. Vaccaro. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Oncologist and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.